会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 2. 发明公开
    • 갯방풍 추출물을 함유하는 암예방 및 치료용 약학적 조성물
    • 用于预防和治疗含有GLEHNIA LITTORALIS提取物的癌症的药物组合物
    • KR1020100037781A
    • 2010-04-12
    • KR1020080097045
    • 2008-10-02
    • 부경대학교 산학협력단
    • 서영완남택정공창숙엄영란김유아이정임
    • A61K36/234A61P35/00
    • A61K36/23A61K2236/33
    • PURPOSE: A pharmaceutical composition for preventing and treating cancer containing Glehnia littoralis extract is provided to suppress proliferation of cancer cells and expression of Inos, COX-2 and Bcl-2 mRNA. CONSTITUTION: A pharmaceutical composition for preventing and treating cancer contains Glehnia littoralis-derived extract or fraction as an active ingredient. The littoralis-derived fraction is n-hexane, 85% aqueous MeOH, n-BuOh and H_2O fraction. The pharmaceutical composition for preventing and treating cancer contains a compound isolated from the fraction as an active ingredient. The compound is n-BuOH fraction-derived benzyl-beta-D-glucopyranoside, O-beta-D-apiofuranosyl-(1"→6')-beta-D-glucopyranoside, 1-beta-D-glucosyloxy-2-(3-methoxy-4-hydroxyphenyl-propane-1,3-diol), 85% aqueous MeOH fraction-derived bergapten, isopimpinellin, xanthotoxin, imperatorin, falcaindiol, and n-hexane fraction-derived falcarinol.
    • 目的:提供一种用于预防和治疗含有Glehnia littoralis提取物的癌症药物组合物,用于抑制癌细胞的增殖和Inos,COX-2和Bcl-2 mRNA的表达。 构成:用于预防和治疗癌症的药物组合物含有来源于石菖蒲的提取物或级分作为活性成分。 来自山梨醇的馏分为正己烷,85%MeOH水溶液,n-BuOh和H_2O级分。 用于预防和治疗癌症的药物组合物含有从该级分分离的化合物作为活性成分。 该化合物是由正丁醇部分衍生的苄基-β-D-吡喃葡萄糖苷,O-β-D-二呋喃糖基 - (1“→6')-β-D-吡喃葡萄糖苷,1-β-D-葡糖基氧基-2-( 3-甲氧基-4-羟基苯基 - 丙烷-1,3-二醇),85%甲醇水溶液的级分,异丙肾上腺素,黄素毒素,欧前胡素,糠醛二醇和正己烷级分衍生的卡达林醇。
    • 3. 发明公开
    • 순비기나무 유래 플라보노이드계 화합물을 함유하는 항암용 조성물
    • 来自VITEX ROTUNDIFOLIA的含有FLAVONOID化合物的防腐剂组合物
    • KR1020110039833A
    • 2011-04-20
    • KR1020090096851
    • 2009-10-12
    • 부경대학교 산학협력단
    • 서영완남택정김유아이정임
    • A61K36/85A61P35/00A61K31/12A23L1/30
    • A61K31/352A61K36/85A61K2236/15A61K2236/33A61K2236/39A61K2236/55
    • PURPOSE: A flavonoid compound derived from Vitex rotundifolia is provided to reduce Bcl-2 expression in cancer cells and to induce cancer cell apoptosis. CONSTITUTION: A pharmaceutical composition for preventing and treating cancer contains Vitex rotundifolia extract as an active ingredient. The extract is isolated using methylene chloride or methanol. The extract is also H_2O, n-BuOH, 85% aq. MeOH, or n-hexane fraction. A pharmaceutical composition for preventing or treating cancer contains flavonoid compounds of chemical formula 1 derived from Vitex rotundifolia or pharmaceutically acceptable salt thereof as an active ingredient. The cancer is gastric cancer, fibrosarcoma, or breast cancer. A health food composition for preventing or treating cancer contains Vitex rotundifolia extract as an active ingredient.
    • 目的:提供从Vitex rotundifolia衍生的黄酮类化合物,以减少癌细胞中的Bcl-2表达,并诱导癌细胞凋亡。 构成:用于预防和治疗癌症的药物组合物含有Vitex rotundifolia提取物作为活性成分。 萃取液用二氯甲烷或甲醇分离。 提取物也是H_2O,n-BuOH,85%水溶液。 MeOH或正己烷馏分。 用于预防或治疗癌症的药物组合物含有衍生自Vitex rotundifolia的化学式1的类黄酮化合物或其药学上可接受的盐作为活性成分。 癌症是胃癌,纤维肉瘤或乳腺癌。 用于预防或治疗癌症的保健食品组合物含有Vitex rotundifolia提取物作为活性成分。
    • 4. 发明公开
    • 암세포 증식 억제 효과를 갖는 갯질경 추출물 및 그 제조방법
    • 具有抑制癌细胞增殖的抑制活性的四氢四嗪提取物及​​其制备方法
    • KR1020100040539A
    • 2010-04-20
    • KR1020080099709
    • 2008-10-10
    • 부경대학교 산학협력단
    • 서영완남택정공창숙김유아이정임
    • A61K36/68A61P35/00
    • A61K36/68A23V2200/308A61K2236/51
    • PURPOSE: A Limonium tetragonum extract and a method for producing the same are provided to ensure high effect of suppressing cancer cell proliferation and use as a novel physiologically active substance. CONSTITUTION: A method for producing Limonium tetragonum extract comprises: a step of extracting Limonium tetragonum with organic solvent to obtain a first extract; a step of concentrating the first extract and extracting residual with organic solvent to obtain a second extract; a step of mixing the first and second extract and fractioning the crude extract with n-hexane, 85% of MeOH, n-BuOH and H_2O; and a step of decompressing and drying. A composition for suppressing cancer cell proliferation contains Limonium tetragonum crude extract as an active ingredient.
    • 目的:提供枸杞提取物及其制备方法,以确保抑制癌细胞增殖的高效果并用作新的生理活性物质。 构成:生产枸杞提取物的方法包括:用有机溶剂萃取枸杞子以获得第一提取物的步骤; 浓缩第一提取物并用有机溶剂萃取残余物以获得第二提取物的步骤; 混合第一和第二提取物并将粗提取物与正己烷,85%MeOH,n-BuOH和H 2 O分馏的步骤; 和减压和干燥的步骤。 用于抑制癌细胞增殖的组合物含有作为有效成分的Lim嗪四氢原油提取物。
    • 6. 发明公开
    • 염주괴불주머니 유래 쿠마린계 화합물, 및 이를 함유하는 항암용 조성물
    • 来自CORYDALIS HETEROCARPA的COUMARIN化合物和含有它们的ANTICANCER组合物
    • KR1020110039831A
    • 2011-04-20
    • KR1020090096849
    • 2009-10-12
    • 부경대학교 산학협력단
    • 서영완남택정김유아이정임
    • C07D493/04C07D311/10A61K31/37A61P35/00
    • PURPOSE: A Corydalis heterocarpa-derived coumarin compound and a pharmaceutical composition containing the same for anticancer is provided to reduce Bcl-2 expression in a cancer cells and to induce cancer cell apoptosis. CONSTITUTION: A coumain compound of chemical formula 1 is derived from Corydalis heterocarpa. A pharmaceutical composition for treating or preventing cancer contains the coumarin compound of chemical formula 1 or pharmaceutically acceptable salt thereof as an active ingredient. A pharmaceutical composition for preventing or treating cancer contains coumarin compound of chemical formula 2 or pharmaceutically acceptable salt thereof as an active ingredient. A health food composition for preventing or treating cancer contains Corydalis heterocarpa extract as an active ingredient.
    • 目的:提供延胡索异焦皮衍生的香豆素化合物和含有抗癌药物的药物组合物,以减少癌细胞中的Bcl-2表达,诱导癌细胞凋亡。 构成:化学式1的香豆素化合物衍生自延胡索异焦皮。 用于治疗或预防癌症的药物组合物含有化学式1的香豆素化合物或其药学上可接受的盐作为活性成分。 用于预防或治疗癌症的药物组合物含有化学式2的香豆素化合物或其药学上可接受的盐作为活性成分。 用于预防或治疗癌症的保健食品组合物含有紫草提取物作为活性成分。